1. Many adverse drug reactions could be prevented

   Newsletter Article 04 February 2013 Pages: 1 - 1

2. The mechanisms of apticoagulant and antibiotic interactions

   Newsletter Article 04 February 2013 Pages: 2 - 2

3. Azapropazone, aspirin and renal toxicity

   Newsletter Article 04 February 2013 Pages: 2 - 2

4. Management and prevention of theophylline toxicity

   Newsletter Article 04 February 2013 Pages: 2 - 2

5. Acetaminophen overdose

   Newsletter Article 04 February 2013 Pages: 3 - 3

6. Acetazolamide

   Newsletter Article 04 February 2013 Pages: 3 - 3

7. Amikacin overdose

   Newsletter Article 04 February 2013 Pages: 3 - 3

8. Cancer chemotherapy

   Newsletter Article 04 February 2013 Pages: 3 - 3

9. Captopril*

   Newsletter Article 04 February 2013 Pages: 3 - 4

10. Carbamazepine

    Newsletter Article 04 February 2013 Pages: 4 - 4

11. Chloramphenicol overdose

    Newsletter Article 04 February 2013 Pages: 4 - 4

12. Chinese ‘herbal’ pills

    Newsletter Article 04 February 2013 Pages: 4 - 4

13. Cimetidine

    Newsletter Article 04 February 2013 Pages: 4 - 4

14. Diethylcarbazine*

    Newsletter Article 04 February 2013 Pages: 4 - 4

15. Digoxin

    Newsletter Article 04 February 2013 Pages: 4 - 5

16. Fenclofenac

    Newsletter Article 04 February 2013 Pages: 5 - 5

17. Flucloxacillin + ampicillin

    Newsletter Article 04 February 2013 Pages: 5 - 5

18. Gentamicin

    Newsletter Article 04 February 2013 Pages: 5 - 5

19. Guanethidine

    Newsletter Article 04 February 2013 Pages: 5 - 5

20. Karaya gum

    Newsletter Article 04 February 2013 Pages: 5 - 5

21. Labetalol

    Newsletter Article 04 February 2013 Pages: 5 - 6

22. Lithium

    Newsletter Article 04 February 2013 Pages: 6 - 6

23. Methoxsalen*

    Newsletter Article 04 February 2013 Pages: 6 - 6

24. Molindone

    Newsletter Article 04 February 2013 Pages: 6 - 6

25. Nitrofurantoin

    Newsletter Article 04 February 2013 Pages: 6 - 6

26. Oral contraceptives interaction* see Tetracycline

    Newsletter Article 04 February 2013 Pages: 6 - 6

27. Penicillamine

    Newsletter Article 04 February 2013 Pages: 6 - 6

28. Penicillin

    Newsletter Article 04 February 2013 Pages: 6 - 6

29. Perhexiline maleate

    Newsletter Article 04 February 2013 Pages: 6 - 7

30. Phenelzine

    Newsletter Article 04 February 2013 Pages: 7 - 7

31. Prednisone

    Newsletter Article 04 February 2013 Pages: 7 - 7

32. Psyllium bulk laxative*

    Newsletter Article 04 February 2013 Pages: 7 - 7

33. Quinidine

    Newsletter Article 04 February 2013 Pages: 7 - 7

34. Sulfinpyrazone interaction

    Newsletter Article 04 February 2013 Pages: 7 - 7

35. Tetracycline interaction*

    Newsletter Article 04 February 2013 Pages: 7 - 7

36. Warfarin interaction see Sulfinpyrazone

    Newsletter Article 04 February 2013 Pages: 7 - 7

37. Miconazole for systemic use

    Newsletter Article 04 February 2013 Pages: 8 - 8

38. The effects of phencyclidine on the fetus

    Newsletter Article 04 February 2013 Pages: 9 - 9

39. Two deaths associated with the use of cyclohexamine

    Newsletter Article 04 February 2013 Pages: 9 - 9

40. Child ingests podophyllin wart solution in the UK

    Newsletter Article 04 February 2013 Pages: 9 - 9

41. Ingestion of ‘Vacor’ rat polson

    Newsletter Article 04 February 2013 Pages: 9 - 10

42. Chlordecone-induced, reversible liver changes in factory workers

    Newsletter Article 04 February 2013 Pages: 10 - 10

43. Arsenic toxicity in a chronic wine drinker

    Newsletter Article 04 February 2013 Pages: 10 - 10

44. How does lithium affect the kidneys?

    Newsletter Article 04 February 2013 Pages: 10 - 11

45. Problem eye and skin effects of chronic phenothiazine therapy

    Newsletter Article 04 February 2013 Pages: 11 - 11

46. Oral contraceptives and liver tumors

    Newsletter Article 04 February 2013 Pages: 11 - 12